Abstract
We report here that fat mass and obesity-associated protein (FTO) has efficient oxidative demethylation activity targeting the abundant N6-methyladenosine (m6A) residues in RNA in vitro. FTO knockdown with siRNA led to increased amounts of m6A in mRNA, whereas overexpression of FTO resulted in decreased amounts of m6A in human cells. We further show the partial colocalization of FTO with nuclear speckles, which supports the notion that m6A in nuclear RNA is a major physiological substrate of FTO.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications
Biomarker Research Open Access 17 April 2023
-
Functions of N6-methyladenosine in cancer metabolism: from mechanism to targeted therapy
Biomarker Research Open Access 13 April 2023
-
RNA N6-methyladenosine modification in female reproductive biology and pathophysiology
Cell Communication and Signaling Open Access 09 March 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout



Change history
03 July 2012
In the version of this article initially published, one of the institute affiliations of co–first author Xu Zhao and coauthors Ying Yang and Yun-Gui Yang was not included. The affiliations statement has been corrected in the HTML and PDF versions of the article.
References
Scott, L.J. et al. Science 316, 1341–1345 (2007).
Frayling, T.M. et al. Science 316, 889–894 (2007).
Dina, C. et al. Nat. Genet. 39, 724–726 (2007).
Thorleifsson, G. et al. Nat. Genet. 41, 18–24 (2009).
Fischer, J. et al. Nature 458, 894–898 (2009).
Church, C. et al. Nat. Genet. 42, 1086–1092 (2010).
Gerken, T. et al. Science 318, 1469–1472 (2007).
Kurowski, M.A., Bhagwat, A.S., Papaj, G. & Bujnicki, J.M. BMC Genomics 4, 48 (2003).
Westbye, M.P. et al. J. Biol. Chem. 283, 25046–25056 (2008).
Aas, P.A. et al. Nature 421, 859–863 (2003).
Fu, Y. et al. Angew. Chem. Int. Edn Engl. 49, 8885–8888 (2010).
van den Born, E. et al. Nat. Commun. 2, 172 (2011).
Jia, G. et al. FEBS Lett. 582, 3313–3319 (2008).
Lee, D.H. et al. J. Biol. Chem. 280, 39448–39459 (2005).
Han, Z. et al. Nature 464, 1205–1209 (2010).
Wei, C.M., Gershowitz, A. & Moss, B. Cell 4, 379–386 (1975).
Narayan, P. & Rottman, F.M. Science 242, 1159–1162 (1988).
Horowitz, S., Horowitz, A., Nilsen, T.W., Munns, T.W. & Rottman, F.M. Proc. Natl. Acad. Sci. USA 81, 5667–5671 (1984).
Harper, J.E., Miceli, S.M., Roberts, R.J. & Manley, J.L. Nucleic Acids Res. 18, 5735–5741 (1990).
Bokar, J.A., Shambaugh, M.E., Polayes, D., Matera, A.G. & Rottman, F.M. RNA 3, 1233–1247 (1997).
Xie, S.Q. et al. Mol. Biol. Cell 17, 1723–1733 (2006).
Hall, L.L. et al. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 288, 664–675 (2006).
Lawrence, J.B. & Clemson, C.M. J. Cell Biol. 182, 1035–1038 (2008).
Lamond, A.I. & Spector, D.L. Nat. Rev. Mol. Cell Biol. 4, 605–612 (2003).
He, C. Nat. Chem. Biol. 6, 863–865 (2010).
Acknowledgements
This work is supported by the US National Institutes of Health (NIH) (GM071440 to C.H.), an NIH EUREKA award (GM088599 to C.H. and T.P.) and the Chinese Academy of Sciences (CAS) '100 Talents' Professor Program to Y.-G.Y. Q.D. is supported by the Chicago Biomedical Consortium (CBC). X.Z. and Y.Y. are supported by the Graduate Student Program of the Beijing Institute of Genomics at CAS. T.L. is supported by the CAS Senior Foreign Research Fellow Award (2009S2-1). We thank the CBC and University of Illinois at Chicago Research Resources Center Proteomics and Informatics Services Facility for performing the LC-MS/MS analysis, L.A. Godley for the suggestion and P. Jin for providing the pcDNA3-FTO plasmid. We thank S.F. Reichard for editing the manuscript.
Author information
Authors and Affiliations
Contributions
G.J., Y.F. and C.H. conceived the original idea. G.J., Y.F., X.Z., Y.-G.Y and C.H. designed the experiments with the help of T.P. Biochemistry assays and cellular analysis were performed by G.J., Y.F. and X.Z. with the help of G.Z., C.Y. and Y.Y.; Q.D. carried out the chemical synthesis; T.L. provided advice and the anti-FTO antibody; and G.J., Y.F., Y.-G.Y. and C.H. wrote the paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Methods and Supplementary Results (PDF 21210 kb)
Rights and permissions
About this article
Cite this article
Jia, G., Fu, Y., Zhao, X. et al. N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol 7, 885–887 (2011). https://doi.org/10.1038/nchembio.687
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.687
This article is cited by
-
Emerging roles of m6A RNA modification in cancer therapeutic resistance
Experimental Hematology & Oncology (2023)
-
Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy
Molecular Cancer (2023)
-
The function and clinical implication of YTHDF1 in the human system development and cancer
Biomarker Research (2023)
-
Functions of N6-methyladenosine in cancer metabolism: from mechanism to targeted therapy
Biomarker Research (2023)
-
RNA N6-methyladenosine modification in female reproductive biology and pathophysiology
Cell Communication and Signaling (2023)